Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from Sanofi Pasteur MSD (manufacturer control number # 2016004929) as part of business agreement on 04-MAY-2016. Case received from a HCP via Health Authority on 02-MAY-2016 with the reference number DK-DKMA-WBS-0003335. Case from a physician. A 14-year-old female adolescent patient received GARDASIL, (batch number LOT NOT REP, Dose 1) via intramuscular route on 04-Jul-2008, GARDASIL, (batch number unknown, Dose 2) on 04-Feb-2009, GARDASIL, (batch number unknown, Dose 3) on 02-Jul-2009. The patient experienced Arthralgia in OCT-2009, back pain in OCT-2009, fasciculation skeletal muscle in 2010, discomfort bodily, most legs in 2011, influenza symptoms of joint pain/cramps in 2010, infection tendency in 2010, tiredness in 2010, headache in 2012, visual disturbance, difficulty focusing in 2012, orthostatic dizziness in 2012, concentration difficulty in 2012, throat pain in 2010, abdominal pain in 2011, nausea in 2011, palpitations in 2012, influenza symptoms of joint pain / cramps in 2010, difficulty concentrating in 2012 and could not complete high school, is on education aid on an unknown date. The patient had a medical history of Hypermobility syndrome. The patient''s outcome was reported as not recovered/not resolved. History around adverse reaction: Could not complete high school, is on education aid. Other vaccines: No. Other medicines: Yes.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166